Telix Pharmaceuticals Limited ADR (TLX)

$10.90 +0.69 (6.76%)
Market Cap 3.47B
Revenue (ttm) 803.79M
Net Income (ttm) -7.13M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE 142.86
Profit Margin -0.89%
Debt to Equity Ratio 0.98
Volume 202,500
Avg Vol 184,458
Day's Range N/A - N/A
Shares Out 339.38M
Stochastic %K 90%
Beta -0.11
Analysts Strong Sell
Price Target $20.90

Company Profile

Telix Pharmaceuticals Limited, a commercial-stage biopharmaceutical company, focuses on the development and commercialization of therapeutic and diagnostic radiopharmaceuticals. The company operates through three segments: Precision Medicine, Therapeutics, and Manufacturing Solutions. Its lead therapeutic product candidate is TLX591, a lutetium-labeled radio antibody-drug conjugate (rADC), which is in a Phase 3 clinical trial in patients with advanced prostate cancer. The company develops TLX250...

Industry: Biotechnology
Sector: Healthcare
Phone: 61 3 9093 3855
Address:
55 Flemington Road, Level 4, North Melbourne, Australia
StJohn_TudorJones
StJohn_TudorJones Jun. 18 at 10:39 PM
$TLX looking very promising recently (CMC/FDA overhangs continue to clear, validated by strong accumulation volume) — $AKTS & overall radiopharma equity momentum is strong too $RADX all of this portends well for RADX share-price action if/once RAD101 final Ph2b data hits (to be released any day now) and especially if it coincides with or is followed by a shareholder-friendly RAD101 deal
0 · Reply
RadioIsotope25
RadioIsotope25 Jun. 17 at 2:02 AM
William Blair on Radiopharma https://www.williamblair.com/-/media/downloads/eqr/2026/williamblair_illuminating-the-road-less-traveled-in-biotech-radiopharmaceuticals-fourth-edition.pdf $RADX $AKTS $LNTH $TLX
0 · Reply
cor1
cor1 Jun. 16 at 9:30 PM
$RADX $AKTS $LNTH $CATX $TLX
1 · Reply
RadioIsotope25
RadioIsotope25 Jun. 14 at 9:28 PM
Updated $RADX vs $AKTS $LNTH $CATX $TLX https://chatgpt.com/s/m_6a2f1cedaf4c819193f2e72fe2836dd3
0 · Reply
RadioIsotope25
RadioIsotope25 Jun. 14 at 4:36 PM
Why $RADX could end up bigger than $AKTS $LNTH $TLX https://chatgpt.com/s/m_6a2ed857ad9c8191bdbe4e11df8099a3
1 · Reply
outlawinvestor1
outlawinvestor1 Jun. 3 at 9:10 AM
$TLX nice fierce biotech article. https://www.fiercebiotech.com/biotech/asco-telix-tees-pivotal-test-pluvicto-challenger-while-eyeing-white-space-radio-therapy
0 · Reply
Merlintrader
Merlintrader Jun. 2 at 7:15 AM
$TLX ASCO 2026 Oncology Signals, Part Three: $TLX, $FLGT and $GLSI Show Three Different Ways to Read Mid-Stage and Late-Stage Cancer Data https://www.merlintrader.com/asco-2026-part-three-tlx-flgt-glsi/
1 · Reply
JFais
JFais May. 28 at 6:27 PM
In our "Technicals and Indicators" channel, I try to point out buy points as I see them $TLX $LQDA $CRNX
0 · Reply
RadioIsotope25
RadioIsotope25 May. 28 at 12:31 PM
$30 dollar target. $RADX $AKTS $CATX $TLX
0 · Reply
stockydennis
stockydennis May. 22 at 6:01 PM
$TLX price action ?
0 · Reply
Latest News on TLX
Telix Pharmaceuticals Rises 2.5% as Stock Continues Rebound From Three-Year Low

2026-06-23T09:06:41.000Z - 1 day ago

Telix Pharmaceuticals Rises 2.5% as Stock Continues Rebound From Three-Year Low

Telix Educational Webinar: Neuro-Oncology Portfolio Update and Physician Perspectives on Future Therapeutic Directions

Mon, 22 Jun 2026 17:40:00 -0400 - 2 days ago

Telix Educational Webinar: Neuro-Oncology Portfolio Update and Physician Perspectives on Future Therapeutic Directions

Telix Pharmaceuticals Transcript: Jefferies Global Healthcare Conference 2026

Jun 3, 2026, 11:40 AM EDT - 21 days ago

Telix Pharmaceuticals Transcript: Jefferies Global Healthcare Conference 2026

Telix Pharmaceuticals Transcript: 46th Annual William Blair Growth Stock Conference

Jun 2, 2026, 9:00 AM EDT - 22 days ago

Telix Pharmaceuticals Transcript: 46th Annual William Blair Growth Stock Conference

Telix Pharmaceuticals Slides: 46th Annual William Blair Growth Stock Conference

Jun 2, 2026, 9:00 AM EDT - 22 days ago

Telix Pharmaceuticals Slides: 46th Annual William Blair Growth Stock Conference

Telix and United Imaging Announce Strategic Theranostics Collaboration

Jun 2, 2026, 7:00 AM EDT - 22 days ago

Telix and United Imaging Announce Strategic Theranostics Collaboration

TLX

ProstACT Global Phase 3 (Part 1) Data Presented in Late-Breaking Oral Session at ASCO 2026

Jun 1, 2026, 5:00 PM EDT - 23 days ago

ProstACT Global Phase 3 (Part 1) Data Presented in Late-Breaking Oral Session at ASCO 2026

TLX

Telix to Participate in William Blair Growth Stock and Jefferies Global Healthcare Conferences

May 27, 2026, 7:00 AM EDT - 4 weeks ago

Telix to Participate in William Blair Growth Stock and Jefferies Global Healthcare Conferences

TLX

Telix Pharmaceuticals Transcript: AGM 2026

May 20, 2026, 8:00 PM EDT - 5 weeks ago

Telix Pharmaceuticals Transcript: AGM 2026

Telix Pharmaceuticals Slides: FY 2026

May 20, 2026, 8:00 PM EDT - 5 weeks ago

Telix Pharmaceuticals Slides: FY 2026

IPAX-2 Study of TLX101-Tx in First-line Glioblastoma Completes Enrolment and Confirms Dosing

May 18, 2026, 5:00 PM EDT - 5 weeks ago

IPAX-2 Study of TLX101-Tx in First-line Glioblastoma Completes Enrolment and Confirms Dosing

TLX

Telix Announces Collaborations to Explore PSMA-PET Imaging in Emerging Prostate Cancer Treatment Approaches

May 15, 2026, 6:30 AM EDT - 5 weeks ago

Telix Announces Collaborations to Explore PSMA-PET Imaging in Emerging Prostate Cancer Treatment Approaches

TLX

New Publication Demonstrates TLX250-Px (Zircaix®) Potential in Diagnosing Kidney Cancers Beyond ccRCC

May 4, 2026, 5:00 PM EDT - 7 weeks ago

New Publication Demonstrates TLX250-Px (Zircaix®) Potential in Diagnosing Kidney Cancers Beyond ccRCC

TLX

TLX101-Px (Pixlumi®) MAA Accepted in Europe

Apr 30, 2026, 5:43 PM EDT - 7 weeks ago

TLX101-Px (Pixlumi®) MAA Accepted in Europe

TLX

Telix Pharmaceuticals Transcript: Status update

Apr 29, 2026, 7:30 PM EDT - 2 months ago

Telix Pharmaceuticals Transcript: Status update

Telix Pharmaceuticals Slides: Status update

Apr 29, 2026, 7:30 PM EDT - 2 months ago

Telix Pharmaceuticals Slides: Status update

OPTIMAL-PSMA Trial of TLX597-Tx Next Generation RLT Presented at IPCS 2026 Highlighting Therapeutic Potential in Prostate Cancer

Apr 29, 2026, 5:00 PM EDT - 2 months ago

OPTIMAL-PSMA Trial of TLX597-Tx Next Generation RLT Presented at IPCS 2026 Highlighting Therapeutic Potential in Prostate Cancer

TLX

Educational Webinar: Unlocking the Potential of PSMA Therapy, A Next‑Generation Portfolio Approach

Apr 27, 2026, 7:27 PM EDT - 2 months ago

Educational Webinar: Unlocking the Potential of PSMA Therapy, A Next‑Generation Portfolio Approach

TLX

ProstACT Global Phase 3 (Part 1) Selected as Late-Breaking Abstract at ASCO 2026

Apr 21, 2026, 4:49 PM EDT - 2 months ago

ProstACT Global Phase 3 (Part 1) Selected as Late-Breaking Abstract at ASCO 2026

TLX

Telix Doses First Patient in Phase 3 IPAX-BrIGHT Trial of TLX101-Tx for Recurrent Glioblastoma

Apr 14, 2026, 7:04 PM EDT - 2 months ago

Telix Doses First Patient in Phase 3 IPAX-BrIGHT Trial of TLX101-Tx for Recurrent Glioblastoma

TLX

Telix and Regeneron Announce Strategic Radiopharma Collaboration

Apr 13, 2026, 6:30 AM EDT - 2 months ago

Telix and Regeneron Announce Strategic Radiopharma Collaboration

TLX

FDA Accepts NDA for TLX101-Px (Pixclara®)

Apr 9, 2026, 6:51 PM EDT - 2 months ago

FDA Accepts NDA for TLX101-Px (Pixclara®)

TLX

Telix Strengthens Board with Additional Director Appointments

Apr 8, 2026, 6:44 PM EDT - 2 months ago

Telix Strengthens Board with Additional Director Appointments

TLX

Q1 2026: Strong Revenue Growth and Therapeutics Pipeline Advancement

Apr 6, 2026, 7:37 PM EDT - 2 months ago

Q1 2026: Strong Revenue Growth and Therapeutics Pipeline Advancement

TLX

Telix Pharmaceuticals Earnings release: Q1 2026

Apr 6, 2026, 6:00 PM EDT - 2 months ago

Telix Pharmaceuticals Earnings release: Q1 2026

Telix Appoints David Gill as Non-Executive Director

Apr 1, 2026, 7:53 PM EDT - 3 months ago

Telix Appoints David Gill as Non-Executive Director

TLX

Telix selects IBA Cyclone® KIUBE to support manufacturing expansion in the U.S.

Mar 20, 2026, 2:00 AM EDT - 3 months ago

Telix selects IBA Cyclone® KIUBE to support manufacturing expansion in the U.S.

TLX

Telix Pharmaceuticals Transcript: Status update

Mar 17, 2026, 3:00 PM EDT - 3 months ago

Telix Pharmaceuticals Transcript: Status update

Telix Resubmits NDA to U.S. FDA for TLX101-Px (Pixclara®) Brain Cancer Imaging Candidate

Mar 15, 2026, 5:25 PM EDT - 3 months ago

Telix Resubmits NDA to U.S. FDA for TLX101-Px (Pixclara®) Brain Cancer Imaging Candidate

TLX

ProstACT Global Phase 3 Study (Part 1) Achieves Primary Objectives

Mar 9, 2026, 7:19 PM EDT - 3 months ago

ProstACT Global Phase 3 Study (Part 1) Achieves Primary Objectives

TLX

Telix Pharmaceuticals Transcript: Study update

Mar 9, 2026, 6:30 PM EDT - 3 months ago

Telix Pharmaceuticals Transcript: Study update

Telix Pharmaceuticals Slides: Study update

Mar 9, 2026, 6:30 PM EDT - 3 months ago

Telix Pharmaceuticals Slides: Study update

Telix Pharmaceuticals Transcript: Status update

Mar 4, 2026, 5:30 PM EST - 4 months ago

Telix Pharmaceuticals Transcript: Status update

Telix Pharmaceuticals Slides: Status update

Mar 4, 2026, 5:30 PM EST - 4 months ago

Telix Pharmaceuticals Slides: Status update

Telix Pharmaceuticals Transcript: TD Cowen 46th Annual Health Care Conference

Mar 2, 2026, 1:50 PM EST - 4 months ago

Telix Pharmaceuticals Transcript: TD Cowen 46th Annual Health Care Conference

Telix Pharmaceuticals Slides: TD Cowen 46th Annual Health Care Conference

Mar 2, 2026, 1:50 PM EST - 4 months ago

Telix Pharmaceuticals Slides: TD Cowen 46th Annual Health Care Conference

Telix Joins Forces with University Hospital Essen on PROMISE-PET: Optimizing Patient Management through AI-enabled PSMA-PET Imaging

Feb 27, 2026, 7:00 AM EST - 4 months ago

Telix Joins Forces with University Hospital Essen on PROMISE-PET: Optimizing Patient Management through AI-enabled PSMA-PET Imaging

TLX

Telix Pharmaceuticals Transcript: Oppenheimer 36th Annual Healthcare Life Sciences Conference

Feb 26, 2026, 4:40 PM EST - 4 months ago

Telix Pharmaceuticals Transcript: Oppenheimer 36th Annual Healthcare Life Sciences Conference

1 Basically Unknown Stock That Could Turn Cancer‑Imaging Breakthroughs Into Generational Wealth

Thu, 26 Feb 2026 05:15:00 -0500 - 4 months ago

1 Basically Unknown Stock That Could Turn Cancer‑Imaging Breakthroughs Into Generational Wealth

FY 2025 Results: Strong Commercial Growth, Focused Pipeline Investment

Feb 19, 2026, 7:02 PM EST - 4 months ago

FY 2025 Results: Strong Commercial Growth, Focused Pipeline Investment

TLX

Telix Pharmaceuticals Earnings Call Transcript: H2 2025

Feb 19, 2026, 5:30 PM EST - 4 months ago

Telix Pharmaceuticals Earnings Call Transcript: H2 2025

Telix Pharmaceuticals Annual report: H2 2025

Feb 19, 2026, 5:30 PM EST - 4 months ago

Telix Pharmaceuticals Annual report: H2 2025

Telix Pharmaceuticals Annual report: H2 2025

Feb 19, 2026, 5:30 PM EST - 4 months ago

Telix Pharmaceuticals Annual report: H2 2025

Telix Pharmaceuticals Slides: H2 2025

Feb 19, 2026, 5:30 PM EST - 4 months ago

Telix Pharmaceuticals Slides: H2 2025

Telix Pharmaceuticals Earnings release: H2 2025

Feb 19, 2026, 5:30 PM EST - 4 months ago

Telix Pharmaceuticals Earnings release: H2 2025

Telix Submits European Marketing Authorization Application for TLX101-Px for Brain Cancer Imaging

Feb 17, 2026, 4:55 PM EST - 4 months ago

Telix Submits European Marketing Authorization Application for TLX101-Px for Brain Cancer Imaging

TLX

Telix Pharmaceuticals Earnings release: Q4 2025

Jan 19, 2026, 6:00 PM EST - 5 months ago

Telix Pharmaceuticals Earnings release: Q4 2025

Telix Pharmaceuticals Transcript: 44th Annual J.P. Morgan Healthcare Conference

Jan 12, 2026, 12:00 PM EST - 5 months ago

Telix Pharmaceuticals Transcript: 44th Annual J.P. Morgan Healthcare Conference

Telix Pharmaceuticals Slides: 44th Annual J.P. Morgan Healthcare Conference

Jan 12, 2026, 12:00 PM EST - 5 months ago

Telix Pharmaceuticals Slides: 44th Annual J.P. Morgan Healthcare Conference

Telix Pharmaceuticals Slides: Investor presentation

Jan 11, 2026, 6:00 PM EST - 5 months ago

Telix Pharmaceuticals Slides: Investor presentation

Levi & Korsinsky Reminds Telix Pharmaceuticals Ltd. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of January 9, 2026 – TLX

Fri, 09 Jan 2026 15:56:00 -0500 - 5 months ago

Levi & Korsinsky Reminds Telix Pharmaceuticals Ltd. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of January 9, 2026 – TLX

TELIX FINAL CLASS ACTION ALERT: Bragar Eagel & Squire, P.C. Urgently Reminds Telix Pharmaceuticals Limited Stockholders to Contact the Firm Regarding Their Rights

Fri, 09 Jan 2026 11:57:00 -0500 - 5 months ago

TELIX FINAL CLASS ACTION ALERT: Bragar Eagel & Squire, P.C. Urgently Reminds Telix Pharmaceuticals Limited Stockholders to Contact the Firm Regarding Their Rights

FINAL DEADLINE ALERT: Faruqi & Faruqi Reminds Telix Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of January 9, 2026

Fri, 09 Jan 2026 10:10:00 -0500 - 5 months ago

FINAL DEADLINE ALERT: Faruqi & Faruqi Reminds Telix Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of January 9, 2026

Telix Pharmaceuticals Ltd. Securities Fraud Class Action Lawsuit Pending: Contact Levi & Korsinsky Before January 9, 2026 to Discuss Your Rights - TLX

Fri, 09 Jan 2026 09:00:00 -0500 - 5 months ago

Telix Pharmaceuticals Ltd. Securities Fraud Class Action Lawsuit Pending: Contact Levi & Korsinsky Before January 9, 2026 to Discuss Your Rights - TLX

TLX FINAL DEADLINE ALERT: Hagens Berman Alerts Telix Pharm. (TLX) Investors of Today's Lead Plaintiff Deadline in Securities Class Action

Fri, 09 Jan 2026 06:49:00 -0500 - 5 months ago

TLX FINAL DEADLINE ALERT: Hagens Berman Alerts Telix Pharm. (TLX) Investors of Today's Lead Plaintiff Deadline in Securities Class Action

TLX Deadline Tomorrow: Rosen Law Firm Encourages Telix Pharmaceuticals Ltd. Investors to Secure Counsel Before Important January 9 Deadline in Securities Class Action First Filed by the Firm – TLX

Thu, 08 Jan 2026 19:00:00 -0500 - 5 months ago

TLX Deadline Tomorrow: Rosen Law Firm Encourages Telix Pharmaceuticals Ltd. Investors to Secure Counsel Before Important January 9 Deadline in Securities Class Action First Filed by the Firm – TLX

Telix Pharmaceuticals Ltd. Sued for Securities Law Violations – Investors Should Contact The Gross Law Firm Before January 9, 2026 to Discuss Your Rights – TLX

Thu, 08 Jan 2026 17:46:00 -0500 - 5 months ago

Telix Pharmaceuticals Ltd. Sued for Securities Law Violations – Investors Should Contact The Gross Law Firm Before January 9, 2026 to Discuss Your Rights – TLX

Deadline Soon: Telix Pharmaceuticals Limited (TLX) Shareholders Who Lost Money Urged To Contact The Law Offices of Frank R. Cruz About Securities Fraud Lawsuit

Thu, 08 Jan 2026 13:04:00 -0500 - 5 months ago

Deadline Soon: Telix Pharmaceuticals Limited (TLX) Shareholders Who Lost Money Urged To Contact The Law Offices of Frank R. Cruz About Securities Fraud Lawsuit

Telix Pharmaceuticals (TLX) Faces Securities Class Action After Alleged Misstatements on Prostate Cancer Drug Progress and Supply Chain Reliability-- Hagens Berman

Thu, 08 Jan 2026 13:00:00 -0500 - 5 months ago

Telix Pharmaceuticals (TLX) Faces Securities Class Action After Alleged Misstatements on Prostate Cancer Drug Progress and Supply Chain Reliability-- Hagens Berman

Bronstein, Gewirtz & Grossman LLC Urges Telix Pharmaceuticals Limited Investors to Act: Class Action Filed Alleging Investor Harm

Thu, 08 Jan 2026 12:00:00 -0500 - 5 months ago

Bronstein, Gewirtz & Grossman LLC Urges Telix Pharmaceuticals Limited Investors to Act: Class Action Filed Alleging Investor Harm

DEADLINE TOMORROW: Berger Montague Advises Telix Pharmaceuticals Ltd. (TLX) Investors to Inquire About a Securities Fraud Class Action by January 9, 2026

Thu, 08 Jan 2026 11:41:00 -0500 - 5 months ago

DEADLINE TOMORROW: Berger Montague Advises Telix Pharmaceuticals Ltd. (TLX) Investors to Inquire About a Securities Fraud Class Action by January 9, 2026

Shareholders that lost money on Telix Pharmaceuticals Ltd.(TLX) should contact The Gross Law Firm about pending Class Action - TLX

Thu, 08 Jan 2026 09:00:00 -0500 - 5 months ago

Shareholders that lost money on Telix Pharmaceuticals Ltd.(TLX) should contact The Gross Law Firm about pending Class Action - TLX

Telix to Present Pipeline and Commercial Portfolio Overview at J.P. Morgan Healthcare Conference

Jan 8, 2026, 6:00 AM EST - 5 months ago

Telix to Present Pipeline and Commercial Portfolio Overview at J.P. Morgan Healthcare Conference

TLX

Telix (TLX) 2-DAY DEADLINE ALERT: Hagens Berman Urges Telix Investors to Act by Jan. 9 in Class Action Suit Over SEC Subpoena & FDA CRL on Manufacturing Failures

Wed, 07 Jan 2026 18:02:00 -0500 - 6 months ago

Telix (TLX) 2-DAY DEADLINE ALERT: Hagens Berman Urges Telix Investors to Act by Jan. 9 in Class Action Suit Over SEC Subpoena & FDA CRL on Manufacturing Failures

Telix Pharmaceuticals Limited (TLX) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit

Wed, 07 Jan 2026 15:30:00 -0500 - 6 months ago

Telix Pharmaceuticals Limited (TLX) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit

INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Telix Pharmaceuticals

Wed, 07 Jan 2026 11:39:00 -0500 - 6 months ago

INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Telix Pharmaceuticals

FRIDAY DEADLINE: Berger Montague Advises Telix Pharmaceuticals Ltd. (NASDAQ: TLX) Investors to Inquire About a Securities Fraud Class Action by January 9, 2026

Wed, 07 Jan 2026 09:01:00 -0500 - 6 months ago

FRIDAY DEADLINE: Berger Montague Advises Telix Pharmaceuticals Ltd. (NASDAQ: TLX) Investors to Inquire About a Securities Fraud Class Action by January 9, 2026

Levi & Korsinsky Notifies Shareholders of Telix Pharmaceuticals Ltd. (TLX) of a Class Action Lawsuit and an Upcoming Deadline

Tue, 06 Jan 2026 16:00:00 -0500 - 6 months ago

Levi & Korsinsky Notifies Shareholders of Telix Pharmaceuticals Ltd. (TLX) of a Class Action Lawsuit and an Upcoming Deadline

TLX Deadline: TLX Investors Have Opportunity to Lead Telix Pharmaceuticals Ltd. Securities Fraud Lawsuit Filed by The Rosen Law Firm

Tue, 06 Jan 2026 15:40:00 -0500 - 6 months ago

TLX Deadline: TLX Investors Have Opportunity to Lead Telix Pharmaceuticals Ltd. Securities Fraud Lawsuit Filed by The Rosen Law Firm

Portnoy Law Firm Announces Class Action on Behalf of Telix Pharmaceuticals Limited Investors

Tue, 06 Jan 2026 10:19:00 -0500 - 6 months ago

Portnoy Law Firm Announces Class Action on Behalf of Telix Pharmaceuticals Limited Investors

Telix Pharmaceuticals Ltd. Sued for Securities Law Violations - Contact Levi & Korsinsky Before January 9, 2026 to Discuss Your Rights - TLX

Tue, 06 Jan 2026 09:00:00 -0500 - 6 months ago

Telix Pharmaceuticals Ltd. Sued for Securities Law Violations - Contact Levi & Korsinsky Before January 9, 2026 to Discuss Your Rights - TLX

Telix Pharmaceuticals Ltd. (TLX) Deadline Approaching: Berger Montague Advises Investors of Deadline in Securities Fraud Lawsuit

Tue, 06 Jan 2026 08:46:00 -0500 - 6 months ago

Telix Pharmaceuticals Ltd. (TLX) Deadline Approaching: Berger Montague Advises Investors of Deadline in Securities Fraud Lawsuit

SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Telix Pharmaceuticals

Mon, 05 Jan 2026 20:14:00 -0500 - 6 months ago

SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Telix Pharmaceuticals

TELIX URGENT CLASS ACTION DEADLINE ALERT: Bragar Eagel & Squire, P.C. Reminds Telix Pharmaceuticals Limited Stockholders to Contact the Firm Regarding Their Rights Before January 9th

Mon, 05 Jan 2026 16:51:00 -0500 - 6 months ago

TELIX URGENT CLASS ACTION DEADLINE ALERT: Bragar Eagel & Squire, P.C. Reminds Telix Pharmaceuticals Limited Stockholders to Contact the Firm Regarding Their Rights Before January 9th

Telix (TLX) 4-DAY DEADLINE ALERT: Hagens Berman Urges Telix Investors to Act by Jan. 9 in Class Action Suit Over SEC Subpoena & FDA CRL on Manufacturing Failures

Mon, 05 Jan 2026 09:09:00 -0500 - 6 months ago

Telix (TLX) 4-DAY DEADLINE ALERT: Hagens Berman Urges Telix Investors to Act by Jan. 9 in Class Action Suit Over SEC Subpoena & FDA CRL on Manufacturing Failures

Precision Medicine Portfolio Update: Illuccix China Phase 3 Study, TLX101-CDx and TLX250-CDx FDA Resubmissions

Dec 21, 2025, 4:38 PM EST - 6 months ago

Precision Medicine Portfolio Update: Illuccix China Phase 3 Study, TLX101-CDx and TLX250-CDx FDA Resubmissions

Telix and Varian Announce Strategic Theranostics-EBRT Clinical Collaboration

Dec 10, 2025, 7:00 AM EST - 7 months ago

Telix and Varian Announce Strategic Theranostics-EBRT Clinical Collaboration

StJohn_TudorJones
StJohn_TudorJones Jun. 18 at 10:39 PM
$TLX looking very promising recently (CMC/FDA overhangs continue to clear, validated by strong accumulation volume) — $AKTS & overall radiopharma equity momentum is strong too $RADX all of this portends well for RADX share-price action if/once RAD101 final Ph2b data hits (to be released any day now) and especially if it coincides with or is followed by a shareholder-friendly RAD101 deal
0 · Reply
RadioIsotope25
RadioIsotope25 Jun. 17 at 2:02 AM
William Blair on Radiopharma https://www.williamblair.com/-/media/downloads/eqr/2026/williamblair_illuminating-the-road-less-traveled-in-biotech-radiopharmaceuticals-fourth-edition.pdf $RADX $AKTS $LNTH $TLX
0 · Reply
cor1
cor1 Jun. 16 at 9:30 PM
$RADX $AKTS $LNTH $CATX $TLX
1 · Reply
RadioIsotope25
RadioIsotope25 Jun. 14 at 9:28 PM
Updated $RADX vs $AKTS $LNTH $CATX $TLX https://chatgpt.com/s/m_6a2f1cedaf4c819193f2e72fe2836dd3
0 · Reply
RadioIsotope25
RadioIsotope25 Jun. 14 at 4:36 PM
Why $RADX could end up bigger than $AKTS $LNTH $TLX https://chatgpt.com/s/m_6a2ed857ad9c8191bdbe4e11df8099a3
1 · Reply
outlawinvestor1
outlawinvestor1 Jun. 3 at 9:10 AM
$TLX nice fierce biotech article. https://www.fiercebiotech.com/biotech/asco-telix-tees-pivotal-test-pluvicto-challenger-while-eyeing-white-space-radio-therapy
0 · Reply
Merlintrader
Merlintrader Jun. 2 at 7:15 AM
$TLX ASCO 2026 Oncology Signals, Part Three: $TLX, $FLGT and $GLSI Show Three Different Ways to Read Mid-Stage and Late-Stage Cancer Data https://www.merlintrader.com/asco-2026-part-three-tlx-flgt-glsi/
1 · Reply
JFais
JFais May. 28 at 6:27 PM
In our "Technicals and Indicators" channel, I try to point out buy points as I see them $TLX $LQDA $CRNX
0 · Reply
RadioIsotope25
RadioIsotope25 May. 28 at 12:31 PM
$30 dollar target. $RADX $AKTS $CATX $TLX
0 · Reply
stockydennis
stockydennis May. 22 at 6:01 PM
$TLX price action ?
0 · Reply
JFais
JFais May. 18 at 10:52 PM
$TLX (L) Telix Pharmaceuticals: PSMA Radiopharmaceutical Player Is Revving Up $LNTH $NVS https://seekingalpha.com/article/4906204-telix-pharmaceuticals-psma-radiopharmaceutical-player-is-revving-up?source=Twitter
1 · Reply
SuperGreenToday
SuperGreenToday May. 18 at 1:22 PM
$TLX
0 · Reply
BioTuesdays
BioTuesdays May. 15 at 3:15 PM
$TLX announced that it has entered into letters of intent to pursue collaborations to explore the investigational use of its PSMA-PET imaging agents Gozellix (kit for the preparation of gallium Ga 68 gozetotide) and Illuccix (kit for the preparation of gallium Ga 68 gozetotide) with high-intensity focused ultrasound (HIFU) for focal prostate cancer ablation and Profound Medical’s $PROF MRI-guided transurethral ultrasound (TULSA) procedure for whole-gland, subtotal, and focal prostate cancer ablation. https://biotuesdays.com/2026/05/15/telix-in-psma-collaboration-with-profound-medical-and-other-prostate-cancer-therapy-players/
0 · Reply
CliffordCapital
CliffordCapital May. 15 at 1:14 PM
$TLX too cheap.
0 · Reply
CHItraders
CHItraders May. 15 at 11:35 AM
TELIX INKS LOI TO PAIR PSMA-PET WITH HIFU ROBOTICS FOR PROSTATE CA $TLX entered letters of intent with $FOCL and $PROF to explore combining its Gozellix and Illuccix PSMA-PET imaging agents with robotic HIFU and other image-guided therapies for localized prostate cancer. 🔹 Focus on patient selection, treatment planning, and post-treatment monitoring 🔹 Goal: better outcomes with less collateral damage (incontinence, impotence) 🔹 Non-promotional scientific and research collaboration push
1 · Reply
MarketBeat
MarketBeat May. 13 at 8:09 AM
https://marketbeat.com/a/8651590/ $TLX Talanx Q1 Earnings Call Highlights
0 · Reply
CEOBuysDisclosures
CEOBuysDisclosures May. 7 at 3:35 AM
$TLX CEO purchased 67,935 shares at $14.67 for a total of $996,738. Behrenbruch Christian now owns 20,742,935 shares. https://ceo-buys.com
0 · Reply
JFais
JFais May. 1 at 1:43 PM
$TLX (L) Look out Pluvicto! $NVS Multi-product strategy in PSMA mirrors diagnostic For TLX-597, inclusion criteria very broad (super sick patients) & primary endpoint is PSA 90% (high bar= green flag) Unique dosimetry to treat earlier line patients + unlock greater efficacy
0 · Reply
RadioIsotope25
RadioIsotope25 Apr. 24 at 1:52 PM
$RADX Probability-adjusted valuation 🔵 RADX RAD101: → 65% × $700M = $455M Therapeutics (combined optionality discounted): → ~10% × $700M = $70M 👉 Total expected value ≈ $525M $CATX $LNTH $PSTV $TLX
0 · Reply
RadioIsotope25
RadioIsotope25 Apr. 15 at 12:03 PM
$RADX The radiopharmaceutical sector is booming in 2026, driven by major investments in targeted cancer therapies (theranostics) and manufacturing expansion. Key updates include AstraZeneca's $15B investment, Telix Pharmaceuticals's… $AZN $TLX $NVS $SMMT
0 · Reply
PickAlpha
PickAlpha Apr. 15 at 11:59 AM
4/6: Telix priced and upsized a convertible-notes offering to $600 mn at 1.50% due 2031 with a $13.85 conversion price | View: Balance-sheet strength improves but dilution and hedge flows create an unclear near-term skew… $TLX $XBI $IBB
0 · Reply